Category:
Prophylactic Biological Products
CAS NO:
2381089-83-2
Standard:
In-house Standards,
Retatrutide is a peptide-based drug that belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists. It is used in the treatment of type 2 diabetes mellitus to help regulate blood sugar levels. Retatrutide works by stimulating the GLP-1 receptors in the pancreas, which leads to increased insulin secretion and decreased glucagon secretion. This helps to lower blood sugar levels and improve glycemic control in patients with diabetes.